- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GSK
Recent news which mentions GSK
Why Sierra Oncology Stock Is Soaring Today
April 13, 2022
From Motley Fool
From Benzinga
From InvestorPlace
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
April 13, 2022
From MarketWatch
From Benzinga
This Exciting Biotech Stock Could Be Your Next 10-Bagger
April 10, 2022
From Motley Fool
3 Pharmaceutical Stocks With Awesome Futures
April 09, 2022
From Motley Fool
3 Things About Pfizer That Smart Investors Know
April 08, 2022
From Motley Fool
From Benzinga
From Benzinga
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
Why Shares of Vir Biotechnology Rose 20.4% This Week
April 01, 2022
From Motley Fool
From Benzinga
From Benzinga
WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
March 30, 2022
From MarketWatch
From Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
From Benzinga
FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV
March 29, 2022
From Benzinga
From Benzinga
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
March 28, 2022
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
From InvestorPlace
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
From Motley Fool
From Motley Fool
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
From Motley Fool
From Benzinga
Where to Invest $100 Right Now
March 25, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.